EXHIBIT 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION
302 OF THE SARBANES-OXLEY ACT OF 2002
I, Michael A. Kramarz,
certify that:
| (1) | I have reviewed this Quarterly Report on Form 10-Q of Oncologix Tech, Inc.; |
| (2) | Based on my knowledge, the Report does not contain any untrue statement of a material fact or omit
to state a material fact necessary in order to make the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by the Report; |
| (3) | Based on my knowledge, the financial statements, and other financial information included in the
Report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant
as of, and for, the periods represented in this report; |
| (4) | The registrant’s other certifying officer and I are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
| (a) | such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant,
including its consolidated subsidiaries, is made known to us by others with these entities, particularly during the period in which
this report is being prepared; |
| (b) | Designed such internal control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
| (c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented
in Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered
by this Report based on such evaluation; and |
| (d) | Disclosed in this Report any change in the registrant’s
internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s
fourth fiscal quarter in case of an annual report) that has materially affected, or is reasonably likely to materially affect,
the registrant’s internal control over financial reporting. |
| (5) | The registrant’s other certifying officer and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrant’s auditors
and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
| (a) | All significant deficiencies and material weaknesses in
the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial
information; and |
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant
role in the registrant’s internal control over financial reporting. |
Dated: January 14, 2015
By: /s/ Michael A. Kramarz
Michael
A. Kramarz
Principal Financial Officer, Principal Accounting Officer and Chief Financial Officer
